Pandey Sanjay, Mishra Rahasya Mani, Pandey Sweta, Shah Vineet, Saxena Renu
Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.
Sao Paulo Med J. 2012;130(4):248-51. doi: 10.1590/s1516-31802012000400008.
Hemoglobin (Hb) D hemoglobinopathies are widespread diseases in northwestern India and usually present with mild hemolytic anemia and mild to moderate splenomegaly. The heterozygous form of Hb D is clinically silent, but coinheritance of Hb D with Hb S or beta-thalassemia produces clinically significant conditions like thalassemia intermedia of moderate severity. Under heterozygous conditions with coinheritance of alpha and beta-thalassemia, patients show a degree of clinical variability. Thus, our aim was to molecularly characterize the Hb D trait among individuals who were clinically symptomatic because of co-inheritance of alpha deletions or any beta-globin gene mutations.
This was a cross-sectional study conducted in an autonomous tertiary-care hospital.
Complete blood count and red cell indices were measured using an automated cell analyzer. Quantitative assessment of hemoglobin Hb F, Hb A, Hb A2 and Hb D was performed by means of high performance liquid chromatography (HPLC). DNA extraction was done using the phenol-chloroform method. Molecular analyses on common alpha deletions and common beta mutations were done using the Gap polymerase chain reaction and Amplification Refractory Mutation System, respectively.
We evaluated 30 patients and found clinical variation in the behavior of Hb D traits. In six patients, the Hb D traits were clinically symptomatic and behaved like those of thalassemia intermedia. Molecular characterization showed that three out of these six were IVS-1-5 positive.
HPLC may not be the gold standard for diagnosing symptomatic Hb D Punjab traits. Hence, standard confirmation should include molecular studies.
血红蛋白(Hb)D血红蛋白病在印度西北部是常见疾病,通常表现为轻度溶血性贫血和轻度至中度脾肿大。Hb D的杂合形式在临床上没有症状,但Hb D与Hb S或β地中海贫血的共同遗传会产生临床上显著的病症,如中度严重的中间型地中海贫血。在α和β地中海贫血共同遗传的杂合条件下,患者表现出一定程度的临床变异性。因此,我们的目的是对因α缺失或任何β珠蛋白基因突变共同遗传而出现临床症状的个体中的Hb D性状进行分子特征分析。
这是一项在一家自主的三级护理医院进行的横断面研究。
使用自动细胞分析仪测量全血细胞计数和红细胞指数。通过高效液相色谱法(HPLC)对血红蛋白Hb F、Hb A、Hb A2和Hb D进行定量评估。采用酚-氯仿法进行DNA提取。分别使用缺口聚合酶链反应和扩增不应突变系统对常见的α缺失和常见的β突变进行分子分析。
我们评估了30名患者,发现Hb D性状的表现存在临床差异。在6名患者中,Hb D性状有临床症状,表现类似于中间型地中海贫血。分子特征分析表明,这6名患者中有3名IVS-1-5呈阳性。
HPLC可能不是诊断有症状的Hb D旁遮普性状的金标准。因此,标准的确诊应包括分子研究。